137 related articles for article (PubMed ID: 20510208)
21. Invasive markers identified by gene expression profiling in pancreatic cancer.
Rogers A; Smith MJ; Doolan P; Clarke C; Clynes M; Murphy JF; McDermott A; Swan N; Crotty P; Ridgway PF; Conlon KC
Pancreatology; 2012; 12(2):130-40. PubMed ID: 22487523
[TBL] [Abstract][Full Text] [Related]
22. Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas.
Sato N; Fukushima N; Maitra A; Iacobuzio-Donahue CA; van Heek NT; Cameron JL; Yeo CJ; Hruban RH; Goggins M
Am J Pathol; 2004 Mar; 164(3):903-14. PubMed ID: 14982844
[TBL] [Abstract][Full Text] [Related]
23. Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells.
Erkan M; Weis N; Pan Z; Schwager C; Samkharadze T; Jiang X; Wirkner U; Giese NA; Ansorge W; Debus J; Huber PE; Friess H; Abdollahi A; Kleeff J
Mol Cancer; 2010 Apr; 9():88. PubMed ID: 20416094
[TBL] [Abstract][Full Text] [Related]
24. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays.
Iacobuzio-Donahue CA; Maitra A; Olsen M; Lowe AW; van Heek NT; Rosty C; Walter K; Sato N; Parker A; Ashfaq R; Jaffee E; Ryu B; Jones J; Eshleman JR; Yeo CJ; Cameron JL; Kern SE; Hruban RH; Brown PO; Goggins M
Am J Pathol; 2003 Apr; 162(4):1151-62. PubMed ID: 12651607
[TBL] [Abstract][Full Text] [Related]
25. The novel tumor angiogenic factor, adrenomedullin-2, predicts survival in pancreatic adenocarcinoma.
Hollander LL; Guo X; Salem RR; Cha CH
J Surg Res; 2015 Aug; 197(2):219-24. PubMed ID: 25982376
[TBL] [Abstract][Full Text] [Related]
26. Expression profiling of microdissected pancreatic adenocarcinomas.
Crnogorac-Jurcevic T; Efthimiou E; Nielsen T; Loader J; Terris B; Stamp G; Baron A; Scarpa A; Lemoine NR
Oncogene; 2002 Jul; 21(29):4587-94. PubMed ID: 12085237
[TBL] [Abstract][Full Text] [Related]
27. Expression profiling identifies microRNA signature in pancreatic cancer.
Lee EJ; Gusev Y; Jiang J; Nuovo GJ; Lerner MR; Frankel WL; Morgan DL; Postier RG; Brackett DJ; Schmittgen TD
Int J Cancer; 2007 Mar; 120(5):1046-54. PubMed ID: 17149698
[TBL] [Abstract][Full Text] [Related]
28. Identification of an agent selectively targeting DPC4 (deleted in pancreatic cancer locus 4)-deficient pancreatic cancer cells.
Wang H; Han H; Von Hoff DD
Cancer Res; 2006 Oct; 66(19):9722-30. PubMed ID: 17018631
[TBL] [Abstract][Full Text] [Related]
29. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
[TBL] [Abstract][Full Text] [Related]
30. Discovery and analysis of pancreatic adenocarcinoma genes using cDNA microarrays.
Jin G; Hu XG; Ying K; Tang Y; Liu R; Zhang YJ; Jing ZP; Xie Y; Mao YM
World J Gastroenterol; 2005 Nov; 11(41):6543-8. PubMed ID: 16425432
[TBL] [Abstract][Full Text] [Related]
31. CEACAM1, a novel serum biomarker for pancreatic cancer.
Simeone DM; Ji B; Banerjee M; Arumugam T; Li D; Anderson MA; Bamberger AM; Greenson J; Brand RE; Ramachandran V; Logsdon CD
Pancreas; 2007 May; 34(4):436-43. PubMed ID: 17446843
[TBL] [Abstract][Full Text] [Related]
32. Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma.
Crnogorac-Jurcevic T; Gangeswaran R; Bhakta V; Capurso G; Lattimore S; Akada M; Sunamura M; Prime W; Campbell F; Brentnall TA; Costello E; Neoptolemos J; Lemoine NR
Gastroenterology; 2005 Nov; 129(5):1454-63. PubMed ID: 16285947
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer.
Holloway SE; Beck AW; Girard L; Jaber MR; Barnett CC; Brekken RA; Fleming JB
J Am Coll Surg; 2005 Mar; 200(3):371-7. PubMed ID: 15737847
[TBL] [Abstract][Full Text] [Related]
34. Significant overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma using real-time quantitative reverse transcription polymerase chain reaction.
Nielsen A; Scarlett CJ; Samra JS; Gill A; Li Y; Allen BJ; Smith RC
J Gastroenterol Hepatol; 2005 Feb; 20(2):256-63. PubMed ID: 15683429
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis.
Bloomston M; Frankel WL; Petrocca F; Volinia S; Alder H; Hagan JP; Liu CG; Bhatt D; Taccioli C; Croce CM
JAMA; 2007 May; 297(17):1901-8. PubMed ID: 17473300
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA expression signatures in intraductal papillary mucinous neoplasm of the pancreas.
Lubezky N; Loewenstein S; Ben-Haim M; Brazowski E; Marmor S; Pasmanik-Chor M; Oron-Karni V; Rechavi G; Klausner JM; Lahat G
Surgery; 2013 May; 153(5):663-72. PubMed ID: 23305591
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of insulin-like growth factor binding protein-5 in pancreatic adenocarcinomas: identification using DNA microarray.
Johnson SK; Dennis RA; Barone GW; Lamps LW; Haun RS
Mol Carcinog; 2006 Nov; 45(11):814-27. PubMed ID: 16865675
[TBL] [Abstract][Full Text] [Related]
38. Microarray expression profile analysis of long non-coding RNAs in pancreatic ductal adenocarcinoma.
Zhou Y; Gong B; Jiang ZL; Zhong S; Liu XC; Dong K; Wu HS; Yang HJ; Zhu SK
Int J Oncol; 2016 Feb; 48(2):670-80. PubMed ID: 26676849
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma.
Rasheed ZA; Yang J; Wang Q; Kowalski J; Freed I; Murter C; Hong SM; Koorstra JB; Rajeshkumar NV; He X; Goggins M; Iacobuzio-Donahue C; Berman DM; Laheru D; Jimeno A; Hidalgo M; Maitra A; Matsui W
J Natl Cancer Inst; 2010 Mar; 102(5):340-51. PubMed ID: 20164446
[TBL] [Abstract][Full Text] [Related]
40. Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression.
Ryu B; Jones J; Blades NJ; Parmigiani G; Hollingsworth MA; Hruban RH; Kern SE
Cancer Res; 2002 Feb; 62(3):819-26. PubMed ID: 11830538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
